DIRS.INFO The most relevant business & tech news

☆ Sanofi to offer insulin product for $35 to all Americans through GoodRx
▼ + stars: | 2023-10-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Americans, regardless of their insurance status, can now access Sanofi 's most widely prescribed insulin for $35 through the prescription drug savings company GoodRx , the companies announced Thursday. But some patients have struggled to access the $35 price point, even with that program in place. President Joe Biden's Inflation Reduction Act also capped monthly insulin costs for Medicare beneficiaries at $35, but it did not provide protection to diabetes patients who have private insurance. Approximately 8.4 million diabetes patients rely on insulin, the American Diabetes Association said.

Persons: Sanofi, Eli Lilly, Joe Biden's Organizations: Sanofi, CVS, Walgreens, Walmart, Sanofi –, Novo Nordisk –, U.S, Pharma, Life Sciences, Centers for Disease Control, American Diabetes Association Locations: Brooklyn, New York, U.S

☆ New Playground, New Court, New Classroom? Thank Ozempic.
▼ + stars: | 2023-10-17 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/those-new-pickleball-courts-thank-ozempic-581899f3

Persons: Dow Jones

☆ Pfizer Looks for a Covid Bottom
▼ + stars: | 2023-10-17 | by ( David Wainer | ) www.wsj.com time to read: 1 min

Persons: Dow Jones Organizations: pharma, pfizer

☆ Those New Pickleball Courts? Thank Ozempic.
▼ + stars: | 2023-10-17 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

Persons: Dow Jones

☆ Pfizer gets upgrade at Jefferies, which says there's a buying opportunity in the pharma giant's stock
▼ + stars: | 2023-10-16 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

Jefferies thinks its time for investors to go long on Pfizer . "In our view, PFE has one of the most intriguing catalyst paths over the next yr in large cap pharma and trades ~15% below where it traded at the start of the COVID pandemic." The analyst added Pfizer has already presented "an impressive innovation framework" that has helped the company adapt to healthcare headwinds, which underpinned the bullish long-term view. "During the pandemic, Pfizer in collaboration with Biontech rolled out COVID vaccines in a historical timeframe. PFE YTD mountain Pfizer stock YTD — CNBC's Michael Bloom contributed to this report.

Persons: Jefferies, Akash Tewari, it's, Tewari, PFE, Biontech, Paxlovid, Michael Bloom Organizations: Pfizer, pharma

☆ The rise and fall of pharma bigwig Rite Aid, which couldn't keep up with rivals Walgreen and CVS
▼ + stars: | 2023-10-16 | by ( Nidhi Pandurangi | Grace Dean | ) www.businessinsider.com time to read: +5 min

Rite Aid filed for voluntary Chapter 11 bankruptcy on Sunday following slumping sales and a series of lawsuits. Rite Aid, which has over 47,000 employees, has struggled in recent years to compete against larger peers like CVS and Walgreens Boots Alliance, as well as Amazon. Rite Aid has faced growing competition from direct-to-consumer pharmacy startups as well as medication deliveries from the likes of Amazon and Uber. Rite Aid also experienced supply chain challenges after changing supplier for many of its perishable consumer goods and shrink "continued to be a significant headwind," Burr said. Representatives for Rite Aid did not immediately respond for Insider's request for further comment beyond sending statements about Stein's appointment and its Chapter 11 bankruptcy filing.

Persons: it's, —, Jeffrey S, Stein, Elizabeth Burr, Heyward Donigan, Donigan, Burr, there'd Organizations: Service, Rite, Walgreens Boots Alliance, Rite Aid, pharma, Aid, Discount, Rite Aid Corporation, PayLess, Walgreens, Albertsons, New York Times Locations: New Jersey, Scranton , Pennsylvania

☆ Stock Market Today: Dow Futures Edge Up; Investors Eye Lululemon, Pfizer
▼ + stars: | 2023-10-16 | by ( ) www.wsj.com time to read: 1 min

The rush to haven assets has abated, but investors remained on edge about the potential for an escalation in the Israel-Hamas conflict to ripple through markets and the world economy. Stock futures edged up, as did Treasury yields. Follow live updates on the conflict here. Lululemon Athletica’s stock gained ground in premarket trading, two days before it will join the S&P 500 index. Pfizer and other Covid-19 vaccine makers' stocks fell after the pharma giant cut its sales outlook.

Persons: paring, Fighting Organizations: Investors, Pfizer, pharma Locations: Israel, Gaza, Lebanon

Companies Grail Inc FollowIllumina Inc FollowBRUSSELS, Oct 12 (Reuters) - U.S. genetic testing company Illumina (ILMN.O) has been ordered by EU antitrust regulators to sell cancer test maker Grail (GRAL.O) after it completed the deal before securing their approval. The gun-jumping cost Illumina a record EU antitrust fine of 432 million euros ($457 million) for such an offence. The EU watchdog ordered Illumina to restore Grail's independence to the same level as prior to its acquisition and to ensure that it is as viable and competitive as before the takeover. Illumina can choose to divest Grail via a trade sale, a capital markets transaction or other methods, but must do it within strict deadlines. The company must keep Grail separate and viable until the sale is completed.

Persons: Illumina, Foo Yun Chee, Philip Blenkinsop Organizations: pharma, EU, European Commission, Thomson

☆ Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials
▼ + stars: | 2023-10-12 | by ( Paulina Likos | ) www.cnbc.com time to read: +13 min

(Todd) Jim Cramer: I believe that the rally in oil was a short squeeze that is now over. (John) Jim Cramer: FTC chair Lina Khan does not have a strong antitrust case against Amazon (AMZN) – her arguments don't make sense. (Norman) Jim Cramer: We like to have something related to the housing cycle that could make money. (James) Jim Cramer: This is more of an art, not a science. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Jim Cramer's, Jeff Marks, Jim Cramer, It's, Todd, Joe Biden, Tom Jorden, Donald, John, it's, Zev Fima, I've, Peter, Marc Benioff, Lina Khan, Khan, David, Rich Galanti, Eli Lilly, LLY, we've, Lilly, clobbered, Mounjaro, Stanley Black, Decker, that's, James, Michael Steinhardt, Rhonda, Vimal Kapur, Darius Adamczyk, Jim Organizations: Investing Club, Federal Reserve, Nvidia, Fed, Apple, Shark, ESPN, Our, Nasdaq, Amazon, Costco, Diabetes, Procter & Gamble, Honeywell, Electric, GE, Raytheon Technologies, CNBC Locations: Russia, China

Operating profit for the fiscal year through August is expected to rise 26% to 374.6 billion yen ($2.52 billion), according to the average estimate of 12 analysts collected by LSEG. The company has forecast 370 billion yen, which would far exceed last year's 297.3 billion yen. Consensus estimates could be underplaying the company's results given the recovery in China, the weak yen, and strong performance in the United States and Europe, said LightStream Research analyst Oshadhi Kumarasiri. "I'm expecting a positive earnings surprise and a strong set of guidance for next year," added Kumarasiri, who publishes on the Smartkarma platform. Fast Retailing's shares are up 22% in 2023, about even with the gain in the benchmark Nikkei index (.N225).

Persons: Tadashi Yanai, Oshadhi Kumarasiri, I'm, Daisuke Tsukagoshi, Uniqlo, Yanai, Rocky Swift, Varun Organizations: Retailing, Japan's, Forbes, Nikkei, Thomson Locations: TOKYO, China, United States, Europe, doldrums, North America

☆ Foreign nationals detained in China
▼ + stars: | 2023-10-11 | by ( ) www.reuters.com time to read: +2 min

Here are some other high-profile cases of foreign nationals detained in China:YANG HENGJUNThe Australian writer has been detained in China for more than three years, and in 2021 was tried in Beijing on undisclosed national security charges. His arrest coincided with worsening relations between Australia and China and a verdict in his case has been repeatedly delayed. JAPANESE BUSINESSMANA Japanese employee of Astellas Pharma Inc, who has not been identified publicly, was detained in Beijing in March on suspicion of espionage, sending a chill through the Japanese business community in China. The Chinese foreign ministry, when asked last month if the Japanese employee had been arrested, said foreign nationals in China must abide by the country's laws or be prosecuted otherwise. KAI LILi, who is Chinese-American, has been detained in China since 2016.

Persons: Cheng Lei, YANG HENGJUN, Yang, ROBERT SCHELLENBERG, Meng Wanzhou, MARK SWIDAN, Katherine Swidan, KAI LI Li, Harrison Li, Laurie Chen, Don Durfee, Robert Birsel Organizations: Astellas Pharma Inc, Kyodo, Huawei, United, Reuters, Thomson Locations: BEIJING, Australian, China, Beijing, Australia, United States, Vancouver, Canada, MARK SWIDAN The Texas, United Nations

☆ Factbox-Foreign Nationals Detained in China
▼ + stars: | 2023-10-11 | by ( Oct. | At A.M. | ) www.usnews.com time to read: +2 min

Persons: Cheng Lei, YANG HENGJUN, Yang, ROBERT SCHELLENBERG, Meng Wanzhou, MARK SWIDAN, Katherine Swidan, KAI LI Li, Harrison Li, Laurie Chen, Don Durfee, Robert Birsel Organizations: Astellas Pharma Inc, Kyodo, Huawei, United, Reuters Locations: BEIJING, Australian, China, Beijing, Australia, United States, Vancouver, Canada, MARK SWIDAN The Texas, United Nations

☆ What are global firms with presence in Israel doing after Hamas attack
▼ + stars: | 2023-10-09 | by ( ) www.reuters.com time to read: +4 min

Following are the steps taken by the companies ranging from airlines to banks:TRAVELSeveral Asian, European and U.S. airlines have suspended direct flights to Tel Aviv. Delta Air Lines (DAL.N):The airline said it continues to monitor events in the region and has made the decision to cancel Delta-operated Tel Aviv flights through Oct. 31. Goldman Sachs (GS.N):The bank's employees at its office in Tel Aviv have been asked to work from home, a spokesperson said. TECHNvidia (NVDA.O):The world's largest maker of chips used for artificial intelligence and computer graphics said it had canceled an AI summit scheduled for Tel Aviv next week. CONSUMER AND RETAILH&M (HMb.ST):The clothing company said its local franchise partner has temporarily closed all stores in Israel.

Persons: Amir Cohen, El, Goldman Sachs, Morgan Stanley, Gautam Adani's, Jensen Huang, PHARMA Eli Lilly, Lilly, Priyamvada C, Mehr Bedi, Ananya Mariam Rajesh, Khushi, Jaiveer Singh, Samrhitha, Helen Reid, Sriraj Kalluvila, Shounak Dasgupta, Shinjini Organizations: Gaza, REUTERS, Palestinian, Hamas, Tel Aviv . Delta Air Lines, Royal, Chevron, JPMorgan Chase, Reuters, Bank of America, Bloomberg News, FedEx, TECH Nvidia, Tel, Inditex SA, PHARMA, Thomson Locations: Sderot, Israel, U.S, Tel Aviv, Royal Caribbean, Haifa Port, Zara, Bengaluru, London

☆ Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
▼ + stars: | 2023-10-09 | by ( Stuart Condie | ) www.wsj.com time to read: 1 min

Persons: Dow Jones Organizations: bristol, myers, squibb

That was until this week, when the company decided to pull its listing in the final hours of Wednesday, blaming market conditions. In the coming weeks, a string of European companies are slated to come to market. Among them is CVC Capital Partners, which is still planning a November listing depending on market conditions, a person with knowledge of the matter told Reuters. However, the fate of Renk highlights the challenges facing new issuers, exacerbated by a recent bout of volatility in equity and debt markets. On Thursday it was trading around its opening IPO price at 30 euros, still above its issue price, a positive sign.

Persons: Andreas Bernstorff, Germany's DAX, Susanne Wiegand, Schott, Perfumery, Douglas, Emma, Victoria Farr, Pablo Mayo Cerqueiro, Alexander Huebner, Anousha Sakoui Organizations: Capital Partners, Reuters, Equity Capital Markets, BNP, Renk, Rheinmetall, Schott Pharma, DKV, CVC Capital Partners, Paris bourse, Thomson Locations: FRANKFURT, LONDON, Frankfurt, U.S, Europe, East, Africa, European, Germany, York, Lincoln

[1/2] Mosquitoes are seen on stagnant water on the roadside during countrywide dengue infection, in Dhaka, Bangladesh, August 24, 2023. REUTERS/Mohammad Ponir Hossain/File Photo Acquire Licensing RightsCompanies Takeda Pharmaceutical Co Ltd FollowLONDON, Oct 6 (Reuters) - Dengue fever will become a major threat in the southern United States, southern Europe and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread. Many cases go unrecorded, but in 2022 4.2 million cases were reported worldwide and public health officials have warned that near-record levels of transmission are expected this year. Qdenga is also approved by the EU regulator, but Takeda withdrew its application in the United States earlier this year, citing data collection issues. Dengue is spread by infected Aedes aegypti mosquitoes, which behave differently to the malaria-carrying kind.

Persons: Mohammad Ponir Hossain, ” Jeremy Farrar, ” Farrar, Farrar, ”, “, Takeda, Jennifer Rigby, Michele Gershberg, Sharon Singleton Organizations: REUTERS, Takeda Pharmaceutical, World Health Organization, Reuters, Wellcome, WHO, Takeda Pharmaceuticals, U.S . Food, Drug Administration, Thomson Locations: Dhaka, Bangladesh, United States, Europe, Africa, Asia, Latin America, Vietnam, Saharan Africa, EU

☆ Here are Thursday's biggest analyst calls: Nvidia, Meta, Ford, Wingstop, American Express and more
▼ + stars: | 2023-10-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Bank of America initiates Wingstop as buy Bank of America said shares of the wing restaurant company are attractive. " Bank of America downgrades Carrier to underperform from neutral Bank of America said it sees residential headwinds. "We are initiating on the Alternative Asset Management sector with a Market Overweight rating. Deutsche Bank initiates AIG as buy Deutsche Bank initiated the insurance company with a buy and says shares are de-risked. Bank of America reiterates American Express as a top pick Bank of America said the credit card company is its favorite idea in the sector. "

Persons: Stifel, Wedbush, Morgan Stanley, Ford, CARR, Parker, ITW, Raymond James downgrades Clorox, Raymond James, CLX, Johnson, Wolfe, Bernstein, Chubb Organizations: BMO, Sinclair, Oculis, Citizens, CIT Group, Bank, JPMorgan, Barclays, Meta, Bank of America, Ford, General Motors, GM, UAW, of America, Nvidia, ISI, RBC, Johnson, Pharma, KKR, Alternative, Management, Asset Management, CART, Deutsche Bank, AIG, Citi, O'Reilly Automotive, O'Reilly, American Express Locations: CY24, U.S

☆ German defense contractor postpones IPO on eve of debut
▼ + stars: | 2023-10-05 | by ( Jenni Reid | ) www.cnbc.com time to read: +2 min

German defense contractor Renk on late Wednesday announced it would indefinitely postpone its initial public offering on the Frankfurt Stock Exchange scheduled for the following morning. "In the past days, the market environment has clouded noticeably," the company said in a statement, providing no further details. Shares were set to be offered in a price range between 15 euros ($15.77) and 18 euros, with a total placement volume between 405 million and 486 million euros. It reported an increase in audited gross profit from 124.5 million euros to 164.8 million euros in the fiscal year ending on Dec. 31 2022. European bourses had a mixed first half of the year, with funds raised through listings on the Paris Stock Exchange plunging 92%, while the London Stock Exchange held steady.

Persons: Renk, Susanne Wiegand, bourses, Susannah Streeter, Hargreaves Lansdown Organizations: Frankfurt Stock Exchange, CNBC, Triton, Reuters, Paris Stock Exchange, London Stock Exchange, Schott Pharma, Hargreaves Locations: Augsburg, Germany, Ukraine, Frankfurt

☆ This health care giant has 'unlocked potential' after a recent spinoff, RBC says
▼ + stars: | 2023-10-05 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Johnson & Johnson is a buy after the company's consumer business spinoff earlier this year, according to RBC Capital Markets. The firm initiated Johnson & Johnson with an outperform rating and $178 price target, which suggests shares can climb about 14.5% from Wednesday's close. This separation has "unlocked potential" for Johnson & Johnson going forward, analyst Shagun Singh said. Singh also said the company's pharma franchise is poised to deliver competitive growth and that its medtech division is on pace to achieve "top-tier growth and profitability." The analyst added that Johnson & Johnson is trading below its historical multiples despite its improved financial profile since its Kenvue spinoff and that the company has potential upside from further M & A activity.

Persons: Johnson, Shagun Singh, Singh, —, — CNBC's Michael Bloom Organizations: RBC Capital Markets, Johnson, Pharma, company's pharma Locations: Wednesday's

WINCHESTER, Va. (AP) — An animal trainer featured in the popular Netflix series “Tiger King” has received a suspended two-year sentence after being convicted of wildlife trafficking in Virginia, the state attorney general’s office announced. Antle was accused of illegally buying endangered lion cubs in Frederick County, Virginia, for display and profit at his South Carolina zoo. A jury convicted him in June of two felony counts each of wildlife trafficking and conspiring to wildlife traffic. Antle, who owns the Myrtle Beach Safari, appeared in “Tiger King: Murder, Mayhem and Madness,” a Netflix documentary miniseries that focused on tiger breeders. “In Virginia, we uphold the rule of law without exception, whether dealing with violent repeat offenders, big pharma, fraudsters and scammers, or wildlife traffickers,” he said.

Persons: ”, general’s, Doc ” Antle, Jason Miyares, Antle, Miyares, “ Organizations: Netflix, Prosecutors, fraudsters Locations: Va, Virginia, Frederick County , Virginia, Carolina, Myrtle

☆ Stocks making the biggest moves premarket: Cal-Maine Foods, Intel, Apple & more
▼ + stars: | 2023-10-04 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Intel — Shares popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years. The firm is bullish on the stock thanks to progress on legacy projects and said Fluor is on the brink of a company turning point. Sunrun , Sunnova Energy International — Shares of Sunrun and Sunnova dropped 3% and 2.8%, respectively, after Truist Securities downgraded the solar panel installers to hold from buy on Wednesday. Cal-Maine Foods — The stock plunged 11.6% after the company came out with disappointing sales figures due to lower prices.

Persons: Fluor, Sunnova, Moderna, StreetAccount, — CNBC's Brian Evans, Lisa Han Organizations: Intel, UBS, Apple, Sunnova Energy, Truist Securities, Moderna, pharma, Bank of America, Novartis —, Swiss drugmaker, Sandoz, SIX Swiss Exchange, Maine Foods, Revenue Locations: United States, Israel, Swiss, Cal

☆ Sandoz owners are banking on margin cure
▼ + stars: | 2023-10-04 | by ( ) www.reuters.com time to read: +2 min

LONDON, Oct 4 (Reuters Breakingviews) - Sandoz’s (SDZ.S) investors are giving CEO Richard Saynor the benefit of the doubt. Shares in the generics drug maker, which $217 billion pharma giant Novartis (NOVN.S) has finally managed to spin off, started to trade in Zurich on Wednesday. There was a risk that Novartis investors, who have long called for a sale or spinoff, would quickly dump the new Sandoz shares. At current market prices, Sandoz is worth nearly $11 billion, or $14.4 billion once net debt is added in. For now, Novartis investors seem to believe Sandoz’s treatment may be effective.

Persons: Richard Saynor, Sandoz, Aimee Donnellan, Lisa Jucca, Streisand Neto Organizations: Reuters, Novartis, Sandoz, Hikma Pharmaceuticals, X, Brookfield pounces, Temasek, Thomson Locations: Zurich, That’s

☆ Summit Global Investments CEO: Position equities defensively and pick up yield in bonds
▼ + stars: | 2023-10-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSummit Global Investments CEO: Position equities defensively and pick up yield in bondsDavid Harden, Summit Global Investments CEO, Guy Lebas, chief fixed income strategist with Janney Montgomery Scott, and CNBC's Steve Liesman join 'The Exchange' to discuss climbing ten-year yields, U.S. interest rate risk brought on by central banks around the world, and defensive equity investments in consumer staples and pharma technology.

Persons: David Harden, Guy Lebas, Janney Montgomery Scott, Steve Liesman Organizations: Summit Global Investments, pharma

☆ Watch CNBC's interview with Summit Global Investments' David Harden and Janney Montgomery Scott's Guy Lebas
▼ + stars: | 2023-10-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's interview with Summit Global Investments' David Harden and Janney Montgomery Scott's Guy LebasDavid Harden, Summit Global Investments CEO, Guy Lebas, chief fixed income strategist with Janney Montgomery Scott, and CNBC's Steve Liesman join 'The Exchange' to discuss climbing ten-year yields, U.S. interest rate risk brought on by central banks around the world, and defensive equity investments in consumer staples and pharma technology.

Persons: David Harden, Janney Montgomery, Guy Lebas David Harden, Guy Lebas, Janney Montgomery Scott, Steve Liesman Organizations: Summit Global Investments, pharma

Also included is diabetes treatment Jardiance, which was used by nearly 1.6 million Medicare enrollees and had a 2022 out-of-pocket cost per enrollee of $490. In all last year, 9 million seniors and other Medicare beneficiaries paid more than $3.4 billion on these 10 drugs alone, the White House said. “For decades, drug companies in America made record profits while big pharma worked to block Medicare from being able to negotiate lower drug prices for seniors. Even with with Tuesday's prescription drugs announcement, however, the process could still be complicated by lawsuits from drugmakers and sharp criticism from Republicans. Biden noted that the drug manufacturers' agreeing to participate followed a court decision allowing Medicare price negotiation plans to move forward.

Persons: Joe Biden, White, “, ” Biden, Biden, ” Organizations: WASHINGTON, Medicare, Services, Democratic, Biden Locations: America, Atlanta

Search resuls for: "PHARMA"

25 mentions found